Results 51 to 60 of about 2,202,845 (238)
Myocardial Involvement in a Patient with Systemic Sclerosis
Journal of Clinical Rheumatology and ImmunologyMyocarditis is an uncommon presentation in systemic sclerosis. We report the case of a patient who developed myocarditis on the initial diagnosis of systemic sclerosis and was successfully managed with optimal medical treatment, including ...
Chris Ching Lam Cheung, Wan Man Choi
doaj +1 more source
X-ray Phase Contrast Tomography to assess the sequential evolution of multi-organ damage in an animal model of multiple sclerosis [PDF]
arXiv, 2022 We use X-ray phase-contrast tomography (XPCT) in a multi-organ approach to identify early imaging markers predictive of multiple sclerosis (MS) in EAE animal model. As the majority of neurodegenerative diseases, MS is characterized by a progressive accumulation of biological deficits across different organs and systems.
arxiv
Diagnostics, 2023 Systemic sclerosis (also known as scleroderma) is a chronic fibrosing autoimmune disease with both skin and multisystem organ involvement. Scleroderma has the highest mortality among all rheumatic diseases.
Dariana-Elena Pătrîntașu +7 more
doaj +1 more source
Connected Health in Multiple Sclerosis: a mobile applications review [PDF]
, 2017 Multiple Sclerosis (MS) is an unpredictable, often disabling disease that can adversely affect any body function; this often requires persons with MS to be active patients who are able to self-manage. There are currently thousands of health applications available but it is unknown how many concern MS.
arxiv +1 more source
Clinics, 2015 OBJECTIVE: Salvia miltiorrhiza has long been used to treat systemic sclerosis. Tanshinone IIA, one of the phytochemicals derived from the roots of Salvia miltiorrhiza, exhibits multiple biological activities.
Mengguo Liu, Ji Yang, Ming Li
doaj +1 more source
Genetics of scleroderma: implications for personalized medicine?
BMC Medicine, 2013 Significant advances have been made in understanding the genetic basis of systemic sclerosis (scleroderma) in recent years. Can these discoveries lead to individualized monitoring and treatment?
Assassi Shervin +3 more
doaj +1 more source
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
American Journal of Respiratory and Critical Care Medicine, 2019 RATIONALE Interstitial lung disease (ILD) represents a major challenge in systemic sclerosis (SSc), but there are no precise, population-based data on its overall impact, limiting opportunities for screening and management strategies.
A. Hoffmann-Vold +12 more
semanticscholar +1 more source
Multiple Sclerosis disease: a computational approach for investigating its drug interactions [PDF]
arXiv, 2020 Multiple Sclerosis (MS) is a chronic and potentially highly disabling disease that can cause permanent damage and deterioration of the central nervous system. In Europe it is the leading cause of non-traumatic disabilities in young adults, since more than 700,000 EU people suffer from MS. Although recent studies on MS pathophysiology have been provided,
arxiv
Case Reports in Immunology, 2017 Systemic sclerosis, or scleroderma, is a complex medical disorder characterized by limited or diffuse skin thickening with frequent involvement of internal organs such as lungs, gastrointestinal tract, or kidneys.
Bumsoo Park +4 more
doaj +1 more source